JAMA
Original Investigation
April 24, 2024
Cynthia Gyamfi-Bannerman, MD, MS; Rebecca G.ÌýClifton, PhD; Alan T. N.ÌýTita, MD, PhD; Sean C.ÌýBlackwell, MD; Monica Longo, MD, PhD; Jessica A.Ìýde Voest, PhD; T. Michael O’Shea, MD, MPH; Sabine Z.ÌýBousleiman, MSN, MSPH; Felecia Ortiz, RN, BSN; Dwight J.ÌýRouse, MD; Torri D.ÌýMetz, MD, MS; George R.ÌýSaade, MD; Kara M.ÌýRood, MD; Kent D.ÌýHeyborne, MD; John M.ÌýThorp Jr, MD; Geeta K.ÌýSwamy, MD; William A.ÌýGrobman, MD, MBA; Kelly S.ÌýGibson, MD; Yasser Y.ÌýEl-Sayed, MD; George A.ÌýMacones, MD, MSCE; Eunice Kennedy Shriver Maternal-Fetal Medicine Units Network
is active quiz
online first
JAMA. 2024; 10.1001/jama.2024.4303
This prospective follow-up study of a randomized clinical trial evaluates whether antenatal corticosteroids administered to birthing parents at risk of late preterm delivery were associated with adverse neurodevelopmental effects on their offspring.
JAMA Pediatrics
Original Investigation
March 11, 2019
Cynthia Gyamfi-Bannerman, MD, MSc; John A. F.ÌýZupancic, MD, ScD; Grecio Sandoval, MA; William A.ÌýGrobman, MD, MBA; Sean C.ÌýBlackwell, MD; Alan T. N.ÌýTita, MD, PhD; Uma M.ÌýReddy, MD, MPH; Lucky Jain, MD, MBA; George R.ÌýSaade, MD; Dwight J.ÌýRouse, MD; Jay D.ÌýIams, MD; Erin A. S.ÌýClark, MD; John M.ÌýThorp Jr, MD; Edward K.ÌýChien, MD, MBA; Alan M.ÌýPeaceman, MD; Ronald S.ÌýGibbs, MD; Geeta K.ÌýSwamy, MD; Mary E.ÌýNorton, MD; Brian M.ÌýCasey, MD; Steve N.ÌýCaritis, MD; Jorge E.ÌýTolosa, MD, MSCE; Yoram Sorokin, MD; J. Peter VanDorsten, MD; for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network
free access
JAMA Pediatr. 2019; 173(5):462-468. 10.1001/jamapediatrics.2019.0032
This secondary analysis of the Antenatal Late Preterm Steroids trial compares the cost-effectiveness of treatment with antenatal corticosteroids with no treatment for women at risk for late preterm delivery.
JAMA Internal Medicine
Original Investigation
July 14, 2008
Suzanne L. West, PhD, MPH; Aimee A. D’Aloisio, PhD; Robert P. Agans, PhD; William D. Kalsbeek, PhD; Natalie N. Borisov, PhD; John M. Thorp, MD
free access
Arch Intern Med. 2008; 168(13):1441-1449. 10.1001/archinte.168.13.1441
JAMA
Article
October 1, 1997
Jeffrey A. Kuller, MD; John M. Thorp Jr, MD; Watson A. Bowes Jr, MD
JAMA. 1997; 278(13):1061-1061. 10.1001/jama.1997.03550130035023
ÁñÁ«ÊÓƵ Neurology
Original Contribution
May 1, 2005
Steven R.ÌýSchwid, MD; John Thorpe, MD; Mohammad Sharief, MD; Magnhild Sandberg-Wollheim, MD; Kottil Rammohan, MD; Jeanette Wendt, MD; Hillel Panitch, MD; Douglas Goodin, MD; David Li, MD; Peter Chang, PhD; Gordon Francis, MD; for the EVIDENCE (Evidence of Interferon Dose-Response: European North American Comparative Efficacy) Study Group and the University of British Columbia MS/MRI Research Group
free access
Arch Neurol. 2005; 62(5):785-792. 10.1001/archneur.62.5.785
JAMA Internal Medicine
Article
February 1, 1980
Robert Kay, MD; William M. Bennett, MD; John Thorpe, MD; John Barry, MD
Arch Intern Med. 1980; 140(2):281-281. 10.1001/archinte.1980.00330140139040